Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Biliary Tract Neoplasms 2

Interventions

Gemcitabine 10Cisplatin 7S 1 (combination) 6titanium silicide 2Oxaliplatin 2spartalizumab 1pembrolizumab 1pamiparib 1atezolizumab 1World Health Organization oral rehydration solution 1Temozolomide 1Paclitaxel 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Biliary Tract Neoplasms × titanium silicide × Clear all
NCT01815307 2018-05-16

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 2 Completed
70 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT01291615 2014-10-23

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 1 Completed
6 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡